Garland Capital Management’s GSK GSK Stock Holding History

Garland Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-55,680	Closed	-$3.81M	–	33
2015 Q4	$3.81M	Buy	55,680 +440	+0.8%	+$22.4K	3.01%	20
2015 Q3	$2.65M	Buy	55,240 +10,640	+24%	+$554K	2.07%	33
2015 Q2	$2.32M	Sell	44,600 -9,880	-18%	-$556K	2.01%	30
2015 Q1	$3.14M	Buy	54,480 +4,640	+9%	+$266K	2.07%	33
2014 Q4	$2.66M	Buy	49,840 +6,280	+14%	+$351K	1.73%	36
2014 Q3	$2.5M	Sell	43,560 -680	-2%	-$41.7K	1.79%	37
2014 Q2	$2.6M	Buy	+44,240	New	+$2.99M	1.74%	37

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Garland Capital Management's GSK Position: Q1 2016 in Review

Garland Capital Management sold out of GSK (GSK) in Q1 2016, closing a stake of 55,680 shares — an estimated $3.81M sold.

Garland Capital Management first reported a position in GSK in Q2 2014 and held it in 7 quarters. The position peaked at $3.81M in Q4 2015. 727 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

Garland Capital Management reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
Garland Capital Management sold 55,680 GSK shares in Q1 2016, an estimated $3.81M.
Garland Capital Management first reported a position in GSK in Q2 2014 and held it in 7 quarters.
Garland Capital Management's GSK position peaked at $3.81M in Q4 2015.
727 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Garland Capital Management's 13F filing for Q1 2016, filed 28 Apr 2016.